Award Notice for Single Donor, Type Specific, Universal Freeze-Dried Plasma Activities for Commercial Sustainability
Award Notice Posted
- Solicitation number
- HT942726CE047
- Agency
- Not on record
- Awarded
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- HT942726CE047
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Maple Grove, Minnesota 55369, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency, through its Contracting Activity (DHACA) on behalf of the Portfolio Acquisition Executive Medical Products and the Warfighter Protection and Acute Care Project Management Office, awarded firm fixed-price Research and Development contract HT942726CE047 to Vascular Solutions LLC, a Teleflex Incorporated subsidiary, for 2775270.78 on September 30, 2026.
The award was a sole-source action under other than full and open competition, justified under 10 U.S.C. 3204(a)(1), with no set-aside used. The 42-month performance period includes a base task from September 30, 2026 through March 30, 2028 and two optional tasks extending through March 30, 2030. Scope covers product lifecycle management for a Single Donor, Type Specific, universal Freeze-Dried Plasma product: shelf-life improvement, characterization studies to expand plasma starting material, international shipping validation, manufacturing process optimization, and next-generation lyophilization bag container development. The award succeeds contract W81XWH-20-C-0088, awarded to Vascular Solutions LLC on September 9, 2020, which concluded December 31, 2025. A Sources Sought Notice posted May 28, 2026 received no responses, and a Notice of Intent posted June 4, 2026 drew responses that were not viable, with one respondent determined incapable of meeting requirements. Octapharma's OctaplasLG Powder was identified as an alternative but not currently viable for this product.
Notice text
Redacted Justification and Approval (J&A) for Other than Full and Open Competition to award a new firm fixed price Research and Development contract to obtain the Product Lifecycle Management (PLM) activities necessary to sustain the commercial viability of a Single Donor, Type Specific, universal Freeze-Dried Plasma (FDP) product made by Vascular Solutions LLC (a subsidiary of Teleflex Incorporated).
Awarded contract HT942726CE047 to Vascular Solutions LLC for 2775270.78 on 2026-09-30.
Files
| File | Type | Posted |
|---|---|---|
| Justification-and-Approval_HT942726RE014_FDP-PLM-v5_signed(2)_redacted_final.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Notice of Intent to Sole Source for Single Donor, Type Specific, Universal Freeze-Dried Plasma Activities for Commercial Sustainability | Special Notice | |
| Sources Sought Notice for Single Donor, Type Specific, Universal Freeze-Dried Plasma Activities for Commercial Sustainability | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems | Defense Health Agency | Service-Disabled Veteran-Owned Small Business |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity